Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

BEI Medical, CryoGen Menorrhagia Ablation Systems Launch April 30

This article was originally published in The Gray Sheet

Executive Summary

Simultaneous FDA approval of BEI Medical Systems' Hydro ThermAblator and CryoGen's HerOption devices for excessive uterine bleeding clears the way for introduction of both systems at the American College of Obstetricians and Gynecologists meeting April 30 in Chicago, the firms say.

You may also be interested in...



AMS’ CryoGen Purchase Anticipates Expanded HerOption Applications

American Medical Systems will seek to extend HerOption endometrial ablation technology for fibroid treatment following the firm's acquisition of CryoGen

AMS’ CryoGen Purchase Anticipates Expanded HerOption Applications

American Medical Systems will seek to extend HerOption endometrial ablation technology for fibroid treatment following the firm's acquisition of CryoGen

Panel Favors First Option, Proposes Study To Address Device Malfunctions

CryoGen should conduct a premarket prospective study of the First Option uterine cryoablation therapy to validate changes made in response to reported device malfunctions, FDA's Obstetrics and Gynecology Devices Panel agreed Jan. 29 in recommending an expanded claim for endometrial ablation.

Related Content

UsernamePublicRestriction

Register

MT014794

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel